Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $87,243 | 35 | 75.8% |
| Food and Beverage | $10,755 | 314 | 9.3% |
| Travel and Lodging | $10,640 | 80 | 9.2% |
| Honoraria | $4,995 | 3 | 4.3% |
| Education | $1,039 | 13 | 0.9% |
| Consulting Fee | $500.00 | 1 | 0.4% |
| Unspecified | $0 | 6 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | $46,815 | 47 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $41,047 | 118 | $0 (2019) |
| ABBVIE INC. | $20,866 | 72 | $0 (2024) |
| Mitsubishi Tanabe Pharma Development America, Inc. | $2,090 | 13 | $0 (2017) |
| Exeltis, USA Inc. | $788.27 | 9 | $0 (2024) |
| Vertical Pharmaceuticals, LLC | $379.29 | 35 | $0 (2019) |
| Astellas Pharma US Inc | $316.53 | 6 | $0 (2024) |
| Allergan, Inc. | $298.60 | 20 | $0 (2020) |
| TherapeuticsMD, Inc. | $276.87 | 14 | $0 (2021) |
| Bayer Healthcare Pharmaceuticals Inc. | $251.63 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21,729 | 45 | MAYNE PHARMA COMMERCIAL LLC ($21,140) |
| 2023 | $26,206 | 59 | MAYNE PHARMA COMMERCIAL LLC ($25,675) |
| 2022 | $4,135 | 30 | ABBVIE INC. ($3,692) |
| 2021 | $17,117 | 54 | AbbVie Inc. ($16,755) |
| 2020 | $543.55 | 31 | AbbVie Inc. ($141.76) |
| 2019 | $1,454 | 55 | Exeltis, USA Inc. ($654.30) |
| 2018 | $25,320 | 100 | AMAG Pharmaceuticals, Inc. ($24,924) |
| 2017 | $18,667 | 78 | AMAG Pharmaceuticals, Inc. ($16,079) |
All Payment Transactions
452 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $18.00 | General |
| 11/27/2024 | PFIZER INC. | ABRYSVO (Biological) | Food and Beverage | In-kind items and services | $21.63 | General |
| Category: VACCINES | ||||||
| 11/22/2024 | CooperSurgical, Inc. | Paragard T 380A (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Endocrinology | ||||||
| 11/08/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: CONTRACEPTIVE | ||||||
| 11/04/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $19.08 | General |
| 10/31/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: HORMONE THERAPY | ||||||
| 10/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Mirena (Drug), Kyleena | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: Womens Health | ||||||
| 10/14/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: ETONOGESTREL | ||||||
| 10/14/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: ETONOGESTREL | ||||||
| 10/08/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 10/03/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $17.12 | General |
| 10/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Biological | ||||||
| 09/24/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $15.64 | General |
| Category: WOMENS HEALTH | ||||||
| 07/16/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $28.35 | General |
| 07/02/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
| 07/01/2024 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Honoraria | Cash or cash equivalent | $675.00 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/26/2024 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,400.00 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/26/2024 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | Cash or cash equivalent | $437.63 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/26/2024 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Travel and Lodging | In-kind items and services | $311.58 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/26/2024 | MAYNE PHARMA COMMERCIAL LLC | NEXTSTELLIS (Drug) | Food and Beverage | In-kind items and services | $121.84 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/06/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: WOMENS HEALTH | ||||||
| 05/31/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug), Mirena | Food and Beverage | In-kind items and services | $23.33 | General |
| Category: Womens Health | ||||||
| 05/10/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $11.25 | General |
| 05/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kyleena (Drug) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: Womens Health | ||||||
| 04/17/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 290 | 304 | $61,119 | $16,285 |
| 2022 | 8 | 225 | 246 | $47,433 | $13,161 |
| 2021 | 9 | 308 | 322 | $44,675 | $17,219 |
| 2020 | 7 | 190 | 197 | $25,685 | $9,189 |
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 65 | 66 | $18,348 | $4,412 | 24.0% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 81 | 81 | $10,125 | $3,567 | 35.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 52 | 60 | $10,260 | $2,617 | 25.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 22 | 22 | $8,668 | $2,071 | 23.9% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2023 | 34 | 34 | $4,488 | $1,553 | 34.6% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 11 | 13 | $4,966 | $1,224 | 24.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 12 | 12 | $4,104 | $785.78 | 19.1% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 16 | $160.00 | $54.56 | 34.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 43 | 53 | $9,063 | $2,368 | 26.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 53 | 53 | $6,625 | $2,365 | 35.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 17 | 17 | $6,817 | $2,361 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 34 | 37 | $10,286 | $2,184 | 21.2% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2022 | 31 | 31 | $4,092 | $1,436 | 35.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 15 | $5,910 | $1,303 | 22.0% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2022 | 20 | 20 | $4,440 | $1,076 | 24.2% |
| 81002 | Urinalysis, manual test | Office | 2022 | 12 | 20 | $200.00 | $69.15 | 34.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 57 | $8,550 | $3,774 | 44.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 81 | 81 | $10,125 | $3,555 | 35.1% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 39 | 50 | $6,000 | $2,164 | 36.1% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 36 | 36 | $5,760 | $2,042 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 19 | 19 | $4,370 | $1,807 | 41.4% |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | Office | 2021 | 28 | 28 | $3,080 | $1,320 | 42.9% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 13 | 13 | $3,770 | $1,275 | 33.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $2,760 | $1,191 | 43.1% |
| 81002 | Urinalysis, manual test | Office | 2021 | 24 | 26 | $260.00 | $90.48 | 34.8% |
About Dr. Mark Firestone, M.D
Dr. Mark Firestone, M.D is a Gynecology healthcare provider based in Aventura, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/09/2006. The National Provider Identifier (NPI) number assigned to this provider is 1558349563.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mark Firestone, M.D has received a total of $115,171 in payments from pharmaceutical and medical device companies, with $21,729 received in 2024. These payments were reported across 452 transactions from 33 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($87,243).
As a Medicare-enrolled provider, Firestone has provided services to 1,013 Medicare beneficiaries, totaling 1,069 services with total Medicare billing of $55,854. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Practice Information
- Specialty Gynecology
- Location Aventura, FL
- Active Since 01/09/2006
- Last Updated 12/15/2025
- Taxonomy Code 207VG0400X
- Entity Type Individual
- NPI Number 1558349563
Products in Payments
- NEXTSTELLIS (Drug) $46,750
- INTRAROSA (Drug) $41,063
- ORIAHNN (Drug) $17,540
- ORILISSA (Drug) $2,770
- LO LOESTRIN FE (Drug) $747.05
- Slynd (Drug) $654.30
- DIVIGEL (Drug) $379.29
- Prolia (Biological) $184.88
- Cologuard Collection Kit (Device) $160.66
- Paragard (Device) $149.80
- ANNOVERA (Drug) $143.39
- NEXPLANON (Drug) $138.25
- SLYND (Drug) $133.97
- Tymlos (Biological) $132.54
- Veozah (Drug) $116.55
- Kyleena (Drug) $107.75
- PREMARIN (Drug) $96.21
- PVC (Drug) $94.34
- Essure (Device) $90.69
- BIJUVA (Drug) $70.63
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.